InsiderTrades

Form 4 for DLB Dolby Laboratories, Inc.

Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-16 · accession 0001209191-22-046521 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2022-08-17 2022-08-16 DLB YEAMAN KEVIN J Pres, CEO, Dir M - OptEx $42.98 +16.7K 38.4K +77% +$717.3K
DI 2022-08-17 2022-08-16 DLB YEAMAN KEVIN J Pres, CEO, Dir S - Sale+OE $80.00 -16.7K 21.7K -43% -$1.34M
DI 2022-08-17 2022-08-16 DLB YEAMAN KEVIN J Pres, CEO, Dir M - OptEx $0.00 -16.7K 171.8K -9% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2022-08-16 M A 16,688 $42.98 38,429 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 — —
2 Common Class A Common Stock 2022-08-16 S D 16,688 $80.00 21,741 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 — —
3 Derivative Employee Stock Option (right to buy) 2022-08-16 M D 16,688 $0.00 171,816 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 $42.98 · — to 2024-12-15 16,688 Class A Common Stock (F2) This option was granted for a total of 291,598 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.